10 Jun 2015 05:30
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
SYR.L Share News (SYR)
SYR Share
Price
SYR Share
News
SYR Share
Chat
SYR Share
Trades
SYR
Live RNS
SYR Share
Charts
SYR Broker
Ratings
SYR Directors
Deals
SYR Financial
Diary
SYR
Fundamentals
SYR Short
Positions
SYR
Media
SYR.L Information
- There is currently no data for SYR
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Synergy Health says no decision yet on US FTC Steris block
Mon, 21st Sep 2015 13:50
(ShareCast News) - Synergy Health said no decision has been made yet on the US Federal Trade Commission's attempt to block the company's takeover by Steris Corp.Synergy is in the process of being taken over by Steris but in June, several key shareholder meetings were postponed by the company after the US FTC said it planned to block the deal on concerns over competition in the market for contract radiation sterilisation services.Synergy and Steris are currently contesting the FTC's move. Synergy said in a statement that although no decision has been made, it is now taking steps to convene meetings to facilitate a timely closing of the combination in the event that the FTC's request is denied.At 1356 BST, Synergy shares were up 1.3% at 1,530p.
More News
9 Jun 2015 14:36
9 Jun 2015 05:28
8 Jun 2015 14:56
8 Jun 2015 05:33
5 Jun 2015 15:03
5 Jun 2015 05:21
4 Jun 2015 15:22
3 Jun 2015 13:25
FTSE 250 movers: Workspace Group and WH Smith surge on strong results
Mid-caps tracked the FTSE 100's gains on Wednesday afternoon despite mixed US data, as strength in the construction and engineering sectors buoyed the market. As of 15:30 BST, the FTSE 250 was trading 0.4% higher at 18,294. Workspace Group led the risers after beating full-year forecasts for profit
Read more2 Jun 2015 08:42
Synergy Health reports 7.5% rise in annual turnover, outlook confident
Synergy Health posted a 7.5% jump in full-year revenue despite adverse currency translation effects and said it was well placed to sustain its growth over both the medium and long-term. The group, which provides specialist outsourced support services to health-related markets, reported a 1.6% rise i
Read more2 Jun 2015 07:57
Tuesday broker round-up
British American Tobacco: JP Morgan reiterates overweight and 4,100p target price. Royal Mail: JP Morgan reiterates neutral stance. Playtech: JP Morgan reiterates buy. Henderson Group: UBS reiterates neutral stance and 275p target. Prudential: UBS reiterates buy recommendation and 1,950p target.
Read more